Alternatives to Gilead Sciences

Developing engineered biologics to harness the immune system for disease treatment.

Biotechnology company developing novel immunotherapies for cancer.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Immunotherapy company targeting oncology and autoimmune diseases.

Biotechnology company developing cell and gene therapies for serious diseases.

Biopharmaceutical company focused on developing orally administered therapeutics for inflammatory disorders and cancer.

Developing transformative fusion immunotherapeutics for autoimmune diseases, cancer, and senescence-associated dysplasia.

Developing immunotherapeutic bi-functional fusion proteins to harness the immune system against cancer.

A global oncology company developing and commercializing innovative cancer treatments.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging the adaptive immune system to diagnose and treat disease.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company developing next-generation gene writing tools for advanced therapies.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Developing novel therapeutics for cancer by targeting the tumor microenvironment.

Pillar Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Develops and manufactures biologics for therapeutic applications.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.